Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Renal Care

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

Therapies
  • Acute Therapy

    Organ support and blood purification therapies are essential to improving patient outcomes in the ICU.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.

  • Hemodialysis

    Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx Therapy

    HDx - also known as expanded hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Groundbreaking research and inspirational patient stories.

  • Clinical Data

    Explore the research enabling innovative Renal Care.

  • Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Resource Library

    Access resources for Baxter’s broader Renal Care portfolio.

PD Cycler With 2-Way Remote Management Technology Reveals Patient Adherence Patterns to Dialysis - Firanek CA, et al.

The Impact of Automated Peritoneal Dialysis (APD) with Remote Patient Management (RPM): Changing the Nursing Paradigm to Proactive Clinical Management - Firanek CA, et al.

Case report: Remote monitoring of automated peritoneal dialysis patients: assessing clinical and economic value - Makhija D, et al

Peritoneal Dialysis: A Scoping Review of Strategies to Maximize PD Utilization - Mann BS, et al.

Trends in outcomes for an automated peritoneal dialysis program with and without remote management in Columbia - Sanabria M, et al.

Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis - Plum J, et al.

Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution - Otte K, et al.

Effect of icodextrin-based dialysis solution on peritoneal leptin clearance - Opatrna S, et al.

Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS) - Marshall J, et al.

Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels - Jones S, et al.

Subscribe to